BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Drug Development

  XBiotech USA Treats First Patient In Phase I/II Clinical Study Of Novel True Human Therapeutic Antibody For Treating Serious Infections Due To Staphylococcus Aureus

  July 6, 2015

   · 

  6 min read
• NeuroDerm Files Registration Statement For Proposed Follow-On Offering

  July 6, 2015

   · 

  1 min read
• Business

  Revance Therapeutics Announces Change In Role Of Jacob Waugh, M.D

  July 6, 2015

   · 

  5 min read
• ESSA Pharma To Commence Trading On The NASDAQ Capital Market

  July 6, 2015

   · 

  4 min read
• Teva’s DuoResp Spiromax Wins Leading Award For Medical Design Excellence

  July 6, 2015

   · 

  7 min read
• Sirtex Medical Release: New SIRFLOX Study Data Presented At World Congress Of Gastrointestinal Cancer

  July 6, 2015

   · 

  5 min read
• BioMidwest

  Centene Corporation To Present At Cantor Fitzgerald Healthcare Conference

  July 6, 2015

   · 

  1 min read
• Business

  Andrew E. Sloan, MD Joins Pharmaco-Kinesis Corporation’s Neuro-Oncology Clinical Advisory Board

  July 6, 2015

   · 

  4 min read
• Pharm Country

  BrainStorm Cell Therapeutics Inc. To Present At Cantor Fitzgerald’s Inaugural Healthcare Conference

  July 6, 2015

   · 

  1 min read
• Drug Development

  ArQule, Inc. Announces Interim Phase II Study Results For Tivantinib In Combination With Cetuximab In Patients With MET-High, KRAS Wild Type Colorectal Cancer Presented At ESMO World Congress On Gastrointestinal Cancer 2015

  July 6, 2015

   · 

  7 min read